{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:19:29Z","timestamp":1778156369923,"version":"3.51.4"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T00:00:00Z","timestamp":1542931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.biopha.2018.09.138","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T22:14:19Z","timestamp":1538432059000},"page":"1188-1200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Gene therapy and type 1 diabetes mellitus"],"prefix":"10.1016","volume":"108","author":[{"given":"Dinesh Kumar","family":"Chellappan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandhini S.","family":"Sivam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai Xiang","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Pan","family":"Leong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai Zhen","family":"Fui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kien","family":"Chooi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fam Jia","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jestin","family":"Chellian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lim Lay","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam","family":"Singhvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Nammi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip Michael","family":"Hansbro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0971-6866.112870","article-title":"Delivery systems for gene therapy","volume":"19","author":"Mali","year":"2013","journal-title":"Indian J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.biopha.2018.09.138_bib0010","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/emmm.201202287","article-title":"Gene therapy on the move","volume":"5","author":"Kaufmann","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI10575","article-title":"Gene therapy in the treatment of autoimmune diseases","volume":"106","author":"Tsokos","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.biopha.2018.09.138_bib0020","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/dmrr.2780","article-title":"Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes","volume":"32","author":"Liu","year":"2016","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2018.09.138_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/genes8080209","article-title":"The genetic architecture of type 1 diabetes","volume":"8","author":"Jerram","year":"2017","journal-title":"Genes"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3390\/genes4030499","article-title":"Genes involved in type 1 diabetes: an update","volume":"4","author":"Bakay","year":"2013","journal-title":"Genes"},{"issue":"8","key":"10.1016\/j.biopha.2018.09.138_bib0035","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2036.2010.04424.x","article-title":"Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology","volume":"32","author":"Touchefeu","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.biopha.2018.09.138_bib0040","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.molmet.2017.05.007","article-title":"AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice","volume":"6","author":"Mallol","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biopha.2018.09.138_bib0045","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4615-3448-8_12","article-title":"Expression of insulin-like growth factors (IGFs) and their binding proteins (IGF BPs) during pancreatic development in rat, and modulation of IGF actions on rat islet DNA synthesis by IGF BPs","volume":"321","author":"Hill","year":"1992","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.biopha.2018.09.138_bib0050","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1189\/jlb.3A0815-371RRR","article-title":"Reg3g overexpression promotes beta cell regeneration and induces immune tolerance in nonobese-diabetic mouse model","volume":"99","author":"Xia","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1515\/bmc.2011.055","article-title":"Regenerating proteins and their expression, regulation and signaling","volume":"3","author":"Parikh","year":"2012","journal-title":"Biomol. Concepts"},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0060","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1006\/mthe.2001.0299","article-title":"Auto-regulated hepatic insulin gene expression in type 1 diabetic rats","volume":"3","author":"Chen","year":"2001","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1517\/14712598.4.4.507","article-title":"Hepatocyte growth factor gene therapy for islet transplantation","volume":"4","author":"Rao","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2018.09.138_bib0070","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.2337\/db15-0066","article-title":"Antiaging gene klotho attenuates pancreatic beta-cell apoptosis in type 1, diabetes","volume":"64","author":"Lin","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0075","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tem.2006.02.002","article-title":"Gene therapy for diabetes: reinventing the islet","volume":"17","author":"Samson","year":"2006","journal-title":"Trends Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.biopha.2018.09.138_bib0080","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1210\/en.2009-0527","article-title":"Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice","volume":"150","author":"Yechoor","year":"2009","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.biopha.2018.09.138_bib0085","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1210\/en.2016-1947","article-title":"Anti-TCRbeta mAb in combination with Neurogenin3 gene therapy reverses established overt type 1 diabetes in female NOD mice","volume":"158","author":"Xie","year":"2017","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.biopha.2018.09.138_bib0090","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1357-2725(00)00028-5","article-title":"Structure-function and biological role of betacellulin","volume":"32","author":"Dunbar","year":"2000","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0095","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1073\/pnas.1016199109","article-title":"Betacellulin promotes cell proliferation in the neural stem cell niche and stimulates neurogenesis","volume":"109","author":"G\u00f3mez-Gaviro","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"14","key":"10.1016\/j.biopha.2018.09.138_bib0100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.biopha.2018.09.138_bib0105","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s001250100628","article-title":"Pancreatic duodenal homeobox-1, PDX-1, a major regulator of beta cell identity and function","volume":"44","author":"McKinnon","year":"2001","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.gt.3302156","article-title":"Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice","volume":"11","author":"Song","year":"2004","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.411","article-title":"Liver glucokinase: an overview on the regulatory mechanisms of its activity","volume":"63","author":"Massa","year":"2011","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0120","first-page":"61","article-title":"Generation of islet-like cell aggregates from human adipose tissue-derived stem cells by lentiviral overexpression of PDX-1","volume":"6","author":"Bahrebar","year":"2015","journal-title":"Int. J. Organ Transplant. Med."},{"issue":"Suppl 22","key":"10.1016\/j.biopha.2018.09.138_bib0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/pedi.12388","article-title":"Insulitis in the pathogenesis of type 1 diabetes","volume":"17","author":"Pugliese","year":"2016","journal-title":"Pediatr. Diabetes"},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1471-4914(02)02279-7","article-title":"Recent advances in insulin gene therapy for type 1 diabetes","volume":"8","author":"Yoon","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0135","first-page":"321","article-title":"Does leptin regulate insulin secretion?","volume":"24","author":"Poitout","year":"1998","journal-title":"Diabetes Metab."},{"issue":"5498","key":"10.1016\/j.biopha.2018.09.138_bib0140","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1126\/science.290.5498.1959","article-title":"Glucose-dependent insulin release from genetically engineered K cells","volume":"290","author":"Cheung","year":"2000","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/gt.2013.50","article-title":"Stable insulin-secreting ducts formed by reprogramming of cells in the liver using a three-gene cocktail and a PPAR agonist","volume":"21","author":"Banga","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2018.09.138_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.intimp.2017.05.023","article-title":"Transplantation of Aire-overexpressing bone marrow-derived dendritic cells delays the onset of type 1 diabetes","volume":"49","author":"Li","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0155","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BOR.0b013e3282fa13b4","article-title":"At the horizon of innovative therapy in rheumatology: new biologic agents","volume":"20","author":"Finckh","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"issue":"11","key":"10.1016\/j.biopha.2018.09.138_bib0160","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jgm.968","article-title":"Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice","volume":"8","author":"Chan","year":"2006","journal-title":"J. Gene Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/viro.2001.1321","article-title":"Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination","volume":"294","author":"Michel","year":"2002","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/14760584.2.4.533","article-title":"Prevention of autoimmune diabetes by DNA vaccination","volume":"2","author":"Prud\u2019homme","year":"2003","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4161\/hv.7.1.12848","article-title":"Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes","volume":"7","author":"Johnson","year":"2011","journal-title":"Hum. Vaccin."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0180","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2337\/db06-0619","article-title":"CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses","volume":"56","author":"Meagher","year":"2007","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.biopha.2018.09.138_bib0185","first-page":"8401","article-title":"CXCL10 DNA vaccination prevents spontaneous diabetes through enhanced beta cell proliferation in NOD mice","volume":"175","author":"Shigihara","year":"2005","journal-title":"J. Immunol. (Baltim. Md.: 1950)"},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032515","article-title":"Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2018.09.138_bib0195","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/db13-1257","article-title":"Combination therapy with an anti-IL-1beta antibody and GAD65 DNA vaccine can reverse recent-onset diabetes in the RIP-GP mouse model","volume":"63","author":"Pagni","year":"2014","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0200","first-page":"149","article-title":"Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?, Nature reviews","volume":"6","author":"Chatenoud","year":"2010","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0205","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaut.2009.10.005","article-title":"Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy","volume":"34","author":"Orban","year":"2010","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.smim.2011.07.003","article-title":"Immune intervention in type 1 diabetes","volume":"23","author":"Michels","year":"2011","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.biopha.2018.09.138_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drudis.2010.05.013","article-title":"Interference with islet-specific homing of autoreactive T cells: an emerging therapeutic strategy for type 1 diabetes","volume":"15","author":"Savinov","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2018.09.138_bib0220","doi-asserted-by":"crossref","first-page":"14013","DOI":"10.1038\/mtm.2014.13","article-title":"Development of gene transfer for induction of antigen-specific tolerance","volume":"1","author":"Sack","year":"2014","journal-title":"Mol. Therapy Methods Clin. Dev."},{"key":"10.1016\/j.biopha.2018.09.138_bib0225","doi-asserted-by":"crossref","DOI":"10.2337\/db15-1418","article-title":"Antigen-encoding bone marrow terminates islet-directed memory CD8+ T-cell responses to alleviate islet transplant rejection","author":"Coleman","year":"2016","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.trsl.2012.12.017","article-title":"Mechanistic basis of immunotherapies for type 1 diabetes mellitus","volume":"161","author":"Chen","year":"2013","journal-title":"Transl. Res."},{"key":"10.1016\/j.biopha.2018.09.138_bib0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2017.01.001","article-title":"Generation of human islet-specific regulatory T cells by TCR gene transfer","volume":"79","author":"Hull","year":"2017","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.biopha.2018.09.138_bib0240","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/01.mjt.0000178774.39149.2d","article-title":"Gene therapy for type 1 diabetes","volume":"12","author":"Giannoukakis","year":"2005","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.biopha.2018.09.138_bib0245","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3389\/fimmu.2017.01313","article-title":"Avidity and bystander suppressive capacity of human regulatory t cells expressing de novo autoreactive T-Cell receptors in type 1 diabetes","volume":"8","author":"Yeh","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0250","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymthe.2016.12.007","article-title":"Adoptive transfer of mRNA-Transfected t cells redirected against diabetogenic CD8 t cells can prevent diabetes","volume":"25","author":"Fishman","year":"2017","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2018.09.138_bib0255","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/gt.2014.45","article-title":"Expression of IL-2 in beta cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells","volume":"21","author":"Flores","year":"2014","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/gt.2016.4","article-title":"IL-15\/sIL-15Ralpha gene transfer induces weight loss and improves glucose homeostasis in obese mice","volume":"23","author":"Sun","year":"2016","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0265","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.3892\/mmr.2015.3809","article-title":"Interleukin-10 gene transfer into insulin-producing beta cells protects against diabetes in non-obese diabetic mice","volume":"12","author":"Xu","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0270","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diabetes.52.3.708","article-title":"Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice","volume":"52","author":"Zhang","year":"2003","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0275","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.smim.2011.07.007","article-title":"Immune intervention with T regulatory cells: past lessons and future perspectives for type 1 diabetes","volume":"23","author":"Battaglia","year":"2011","journal-title":"Semin. Immunol."},{"issue":"1-4","key":"10.1016\/j.biopha.2018.09.138_bib0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12154-008-0003-5","article-title":"Rapamycin and mTOR kinase inhibitors","volume":"1","author":"Ballou","year":"2008","journal-title":"J. Chem. Biol."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0285","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.immuni.2010.04.002","article-title":"Immunotherapy of type 1 diabetes: where are we and where should we be going?","volume":"32","author":"Luo","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2018.09.138_bib0290","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv. Biomed. Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.09.138_bib0295","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr. Gene Ther."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0300","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"issue":"13","key":"10.1016\/j.biopha.2018.09.138_bib0305","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1089\/10430340260201653","article-title":"Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes","volume":"13","author":"Morral","year":"2002","journal-title":"Hum. Gene Ther."},{"issue":"36","key":"10.1016\/j.biopha.2018.09.138_bib0310","doi-asserted-by":"crossref","first-page":"24260","DOI":"10.18632\/oncotarget.24916","article-title":"HX-1171 attenuates pancreatic \u03b2-cell apoptosis and hyperglycemia-mediated oxidative stress via Nrf2 activation in streptozotocin-induced diabetic model","volume":"9","author":"Kim","year":"2018","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.biopha.2018.09.138_bib0315","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.gt.3302260","article-title":"Simultaneous stimulation of Fas-mediated apoptosis and blockade of costimulation prevent autoimmune diabetes in mice induced by multiple low-dose streptozotocin","volume":"11","author":"Jin","year":"2004","journal-title":"Gene Ther."},{"issue":"20","key":"10.1016\/j.biopha.2018.09.138_bib0320","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/sj.gt.3302320","article-title":"Prolongation of islet allograft survival following ex vivo transduction with adenovirus encoding a soluble type 1 TNF receptor-Ig fusion decoy","volume":"11","author":"Machen","year":"2004","journal-title":"Gene Ther."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0325","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/jcb.21677","article-title":"Molecular mechanisms of death ligand-mediated immune modulation: a gene therapy model to prolong islet survival in type 1 diabetes","volume":"104","author":"Sanlioglu","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.biopha.2018.09.138_bib0330","first-page":"68","article-title":"Neo-islet formation in liver of diabetic mice by helper-dependent adenoviral vector-mediated gene transfer","author":"Li","year":"2012","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059222","article-title":"Expression and secretion of human proinsulin-B10 from mouse salivary glands: implications for the treatment of type I diabetes mellitus","volume":"8","author":"Rowzee","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0340","article-title":"Protective effects of combined intervention with adenovirus vector mediated IL-10 and IGF-1 genes on endogenous islet \u03b2 cells in nonobese diabetes mice with onset of type 1 diabetes mellitus","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2018.09.138_bib0345","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3892\/etm.2016.3169","article-title":"Protective role of adenovirus vector-mediated interleukin-10 gene therapy on endogenous islet \u03b2-cells in recent-onset type 1 diabetes in NOD mice","volume":"11","author":"Li","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.biopha.2018.09.138_bib0350","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/gt.2015.18","article-title":"Beta-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection","volume":"22","author":"El Khatib","year":"2015","journal-title":"Gene Ther."},{"issue":"24","key":"10.1016\/j.biopha.2018.09.138_bib0355","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.1073\/pnas.251532298","article-title":"Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice","volume":"98","author":"Goudy","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0360","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1566524013363979","article-title":"Adeno-associated virus (AAV) as a vehicle for therapeutic gene delivery: improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes","volume":"1","author":"Kapturczak","year":"2001","journal-title":"Curr. Mol. Med."},{"issue":"18","key":"10.1016\/j.biopha.2018.09.138_bib0365","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/sj.gt.3301279","article-title":"Adeno-associated virus vector mediated gene transfer to pancreatic beta cells","volume":"7","author":"Prasad","year":"2000","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.biopha.2018.09.138_bib0370","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1172\/JCI22103","article-title":"Prevention of type 1 diabetes by gene therapy","volume":"114","author":"Tian","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 3","key":"10.1016\/j.biopha.2018.09.138_bib0375","doi-asserted-by":"crossref","first-page":"S556","DOI":"10.4103\/2230-8210.105572","article-title":"Long-term correction of type 1 and 2 diabetes by central leptin gene therapy independent of effects on appetite and energy expenditure","volume":"16","author":"Nakano","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0380","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/mp.53.4.173","article-title":"Retroviral vectors","volume":"53","author":"Kurian","year":"2000","journal-title":"Mol. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0385","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02824809","article-title":"Herpes simplex virus vectors for gene therapy","volume":"2","author":"Latchman","year":"1994","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.biopha.2018.09.138_bib0390","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mcn.2016.01.006","article-title":"Viral vector mediated continuous expression of interleukin-10 in DRG alleviates pain in type 1 diabetic animals","volume":"72","author":"Thakur","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.biopha.2018.09.138_bib0395","first-page":"6762","article-title":"Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy","volume":"179","author":"Tian","year":"2007","journal-title":"J. Immunol. (Baltim. Md.: 1950)"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0400","first-page":"76","article-title":"A single treatment with IL-4 via retrovirally transduced lymphocytes partially protects against diabetes in BioBreeding (BB) rats","volume":"3","author":"Zipris","year":"2002","journal-title":"JOP"},{"issue":"5","key":"10.1016\/j.biopha.2018.09.138_bib0405","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/jvi.61.5.1743-1746.1987","article-title":"Replication of latent Epstein-Barr virus genomes in Raji cells","volume":"61","author":"Adams","year":"1987","journal-title":"J. Virol."},{"issue":"18","key":"10.1016\/j.biopha.2018.09.138_bib0410","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1093\/nar\/19.18.5053","article-title":"Replication control of autonomously replicating human sequences","volume":"19","author":"Haase","year":"1991","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0415","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/jvi.65.1.483-488.1991","article-title":"Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells","volume":"65","author":"Yates","year":"1991","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mutage\/3.1.1","article-title":"Recombinant shuttle vectors for the study of mutation in mammalian cells","volume":"3","author":"DuBridge","year":"1988","journal-title":"Mutagenesis"},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0425","first-page":"379","article-title":"Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system","volume":"7","author":"DuBridge","year":"1987","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.biopha.2018.09.138_bib0430","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1073\/pnas.83.10.3402","article-title":"Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency","volume":"83","author":"Drinkwater","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0435","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2006.01.019","article-title":"In vivo gene therapy of type I diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector","volume":"112","author":"Yoo","year":"2006","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.biopha.2018.09.138_bib0440","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jgm.2900","article-title":"Promoter optimisation of lentiviral vectors for efficient insulin gene expression in canine mesenchymal stromal cells: potential surrogate beta cells","volume":"18","author":"Gautam","year":"2016","journal-title":"J. Gene Med."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0445","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2174\/1566523215666150630121557","article-title":"A simple high efficiency intra-islet transduction protocol using lentiviral vectors","volume":"15","author":"Jimenez-Moreno","year":"2015","journal-title":"Curr. Gene Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.09.138_bib0450","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/mt.2012.8","article-title":"Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction","volume":"20","author":"Elsner","year":"2012","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0455","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jgm.2692","article-title":"Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy","volume":"15","author":"Ren","year":"2013","journal-title":"J. Gene Med."},{"key":"10.1016\/j.biopha.2018.09.138_bib0460","series-title":"Gene Based Therapy for Type 1 Diabetes Mellitus: Viral and Non-Viral Vectors","author":"Shrestha","year":"2014"},{"issue":"7","key":"10.1016\/j.biopha.2018.09.138_bib0465","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/j.1460-2075.1982.tb01257.x","article-title":"Gene transfer into mouse lyoma cells by electroporation in high electric fields","volume":"1","author":"Neumann","year":"1982","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.biopha.2018.09.138_bib0470","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1089\/hum.2006.17.890","article-title":"In vivo electroporation for gene therapy","volume":"17","author":"Heller","year":"2006","journal-title":"Hum. Gene Ther."},{"issue":"5","key":"10.1016\/j.biopha.2018.09.138_bib0475","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/mthe.2001.0483","article-title":"Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: plasmid dependence of muscle damage and effect of poloxamer 188","volume":"4","author":"Hartikka","year":"2001","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(98)00987-9","article-title":"Electroporation-mediated gene transfer in cardiac tissue","volume":"435","author":"Harrison","year":"1998","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.biopha.2018.09.138_bib0485","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1110\/ps.04644504","article-title":"Two-promoter vector is highly efficient for overproduction of protein complexes","volume":"13","author":"Kim","year":"2004","journal-title":"Protein Sci."},{"issue":"4","key":"10.1016\/j.biopha.2018.09.138_bib0490","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.phrs.2010.12.009","article-title":"Intramuscular delivery of a naked DNA plasmid encoding proinsulin and pancreatic regenerating III protein ameliorates type 1 diabetes mellitus","volume":"63","author":"Hou","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.biopha.2018.09.138_bib0495","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2337\/db11-1776","article-title":"Nonviral-mediated hepatic expression of IGF-I increases Treg levels and suppresses autoimmune diabetes in mice","volume":"62","author":"Anguela","year":"2013","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0500","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jconrel.2012.08.008","article-title":"Polymeric delivery of therapeutic RAE-1 plasmid to the pancreatic islets for the prevention of type 1 diabetes","volume":"162","author":"Joo","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.biopha.2018.09.138_bib0505","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2011.10.022","article-title":"EphA2 targeting peptide tethered bioreducible poly(cystamine bisacrylamide-diamino hexane) for the delivery of therapeutic pCMV-RAE-1gamma to pancreatic islets","volume":"158","author":"Blevins","year":"2012","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.biopha.2018.09.138_bib0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100369","article-title":"Skin fibroblasts from patients with type 1 diabetes (T1D) can be chemically transdifferentiated into insulin-expressing clusters: a transgene-free approach","volume":"9","author":"Pereyra-Bonnet","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2018.09.138_bib0515","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3727\/096368914X681919","article-title":"Engineered hair follicle mesenchymal stem cells overexpressing controlled-release insulin reverse hyperglycemia in mice with type L diabetes","volume":"24","author":"Wu","year":"2015","journal-title":"Cell Transplant."},{"issue":"11","key":"10.1016\/j.biopha.2018.09.138_bib0520","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.tibtech.2017.07.006","article-title":"Bioprinting and cellular therapies for type 1 diabetes","volume":"35","author":"Ravnic","year":"2017","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.biopha.2018.09.138_bib0525","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12916-015-0426-0","article-title":"Mesenchymal stem\/stromal cells as a delivery platform in cell and gene therapies","volume":"13","author":"D\u2019Souza","year":"2015","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.biopha.2018.09.138_bib0530","first-page":"583","article-title":"Stem cells to restore insulin production and cure diabetes, Nutrition, metabolism, and cardiovascular diseases","volume":"27","author":"Sordi","year":"2017","journal-title":"NMCD"},{"issue":"3","key":"10.1016\/j.biopha.2018.09.138_bib0535","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3727\/096368915X686977","article-title":"Applicability of adipose-derived stem cells in type 1 diabetes mellitus","volume":"24","author":"Lin","year":"2015","journal-title":"Cell Transplant."},{"key":"10.1016\/j.biopha.2018.09.138_bib0540","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.intimp.2017.01.019","article-title":"TGF-beta engineered mesenchymal stem cells (TGF-beta\/MSCs) for treatment of Type 1 diabetes (T1D) mice model","volume":"44","author":"Daneshmandi","year":"2017","journal-title":"Int. Immunopharmacol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218345001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218345001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T06:34:31Z","timestamp":1777271671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218345001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":108,"alternative-id":["S0753332218345001"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.138","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene therapy and type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}